nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Activation status of receptor tyrosine kinase downstream pathways in primary lung adenocarcinoma with reference of KRAS and EGFR mutations
|
Hiramatsu, Miyako |
|
2010 |
70 |
1 |
p. 94-102 9 p. |
artikel |
2 |
A phase II study of pemetrexed and carboplatin as a salvage therapy for platinum-pretreated patients with non-small cell lung cancer
|
Kim, Hyeong Su |
|
2010 |
70 |
1 |
p. 71-76 6 p. |
artikel |
3 |
Belotecan for relapsing small-cell lung cancer patients initially treated with an irinotecan-containing chemotherapy: A phase II trial
|
Jeong, Jaeheon |
|
2010 |
70 |
1 |
p. 77-81 5 p. |
artikel |
4 |
Chemoprevention of murine lung cancer by gefitinib in combination with prostacyclin synthase overexpression
|
Keith, Robert L. |
|
2010 |
70 |
1 |
p. 37-42 6 p. |
artikel |
5 |
Chemotherapy with cetuximab or chemotherapy alone for untreated advanced non-small-cell lung cancer: A systematic review and meta-analysis
|
Lin, Hao |
|
2010 |
70 |
1 |
p. 57-62 6 p. |
artikel |
6 |
Contents
|
|
|
2010 |
70 |
1 |
p. vii-viii nvt p. |
artikel |
7 |
Cystic fibrosis transmembrane conductance regulator gene mutation and lung cancer risk
|
Li, Yafei |
|
2010 |
70 |
1 |
p. 14-21 8 p. |
artikel |
8 |
Diminished lipocalin-type prostaglandin D2 synthase expression in human lung tumors
|
Ragolia, Louis |
|
2010 |
70 |
1 |
p. 103-109 7 p. |
artikel |
9 |
Editorial Board
|
|
|
2010 |
70 |
1 |
p. v- 1 p. |
artikel |
10 |
Endobronchial ultrasound-guided transbronchial needle aspiration in the diagnosis of lung cancer
|
Lee, Jeong Eun |
|
2010 |
70 |
1 |
p. 51-56 6 p. |
artikel |
11 |
Human umbilical cord matrix-derived stem cells expressing interferon-β gene significantly attenuate bronchioloalveolar carcinoma xenografts in SCID mice
|
Matsuzuka, Takaya |
|
2010 |
70 |
1 |
p. 28-36 9 p. |
artikel |
12 |
Imaging in pleural mesothelioma: A review of Imaging Research Presented at the 9th International Meeting of the International Mesothelioma Interest Group
|
Nowak, Anna K. |
|
2010 |
70 |
1 |
p. 1-6 6 p. |
artikel |
13 |
Population-based patterns and cost of management of metastatic non-small cell lung cancer after completion of chemotherapy until death
|
Navaratnam, Sri |
|
2010 |
70 |
1 |
p. 110-115 6 p. |
artikel |
14 |
Reply to Anile et al.
|
Onuki, Takuya |
|
2010 |
70 |
1 |
p. 117- 1 p. |
artikel |
15 |
Surgical treatment of early stage thymoma
|
Anile, Marco |
|
2010 |
70 |
1 |
p. 116- 1 p. |
artikel |
16 |
The clinical significance of the tumor cell D2-40 immunoreactivity in non-small cell lung cancer
|
Kadota, Kyuichi |
|
2010 |
70 |
1 |
p. 88-93 6 p. |
artikel |
17 |
The platinum-based treatments for advanced non-small cell lung cancer, is low/negative ERCC1 expression better than high/positive ERCC1 expression? A meta-analysis
|
Chen, Sufeng |
|
2010 |
70 |
1 |
p. 63-70 8 p. |
artikel |
18 |
The prognostic role of Bcl-2 mRNA expression in curatively resected non-small cell lung cancer (NSCLC)
|
Grimminger, Peter P. |
|
2010 |
70 |
1 |
p. 82-87 6 p. |
artikel |
19 |
Therapy of small cell lung cancer with emphasis on oral topotecan
|
Pirker, Robert |
|
2010 |
70 |
1 |
p. 7-13 7 p. |
artikel |
20 |
The trajectory of lung cancer patients in Western Australia—A data linkage study: Still a grim tale
|
Jiwa, Moyez |
|
2010 |
70 |
1 |
p. 22-27 6 p. |
artikel |
21 |
Tissue and serum EGFR as prognostic factors in malignant pleural mesothelioma
|
Gaafar, Rabab |
|
2010 |
70 |
1 |
p. 43-50 8 p. |
artikel |